TIMELY: a Patient-centred Lifestyle Program for Patients With Coronary Artery Disease
NCT05955625 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 358
Last updated 2025-08-27
Summary
Study design: A randomized controlled trial will be used, where patients will be randomized (1:1) to either the control group receiving usual care or the intervention group in which patients will receive usual care in combination with the TIMELY intervention for a duration of 6 months.
Study sample: Female and male patients aged 18 years or over, with documented stable CAD and referred for cardiac rehabilitation (at \> 2 weeks but \<10 weeks after PCI or \>4 weeks but \<12 weeks after CABG or MI: STEM or non-STEMI), and/or having documented CAD by coronary angiography (stenosis in a major coronary artery \>50%).
Intervention: Patients randomized to the intervention group will receive the TIMELY app on their phones or tablets for 6 months. Patients will also receive a wearable activity tracker that collects activity levels, heart rate and sleep characteristics. Based on patient's activity levels, self-reported momentary mental states, health-related behaviors and environmental and clinical background factors, the app will enable patient-tailored recommendations relevant to improving lifestyle behaviors during daily life. In addition, patients will receive a blood pressure monitor that measures hemodynamic parameters through pulse wave analysis and an easy-to-use ECG device which will be used to assess changes in heart rate and other cardiovascular measures at rest and with exercise.
Main study parameters/endpoints: The primary biomedical outcome is a change in the CoroPredict biomarker risk score from baseline (pre-randomization) to completion of the active intervention phase (6 months). The CoroPredict score is an indicator of the 10-year risk of mortality. The primary behavioral outcome is the change from baseline to 6 months in patients' functional status of fitness level (measured using the 6-minute walk test). The study further aims to improve secondary outcome measures: physical activity levels during daily life and cardiovascular responses to exercise, dietary habits, smoking behavior, medication adherence and perceived levels of psychological stress.
Conditions
Interventions
- OTHER
-
TIMELY
The TIMELY app works with several devices, including a wearable activity tracker that collects activity levels, heart rate and sleep characteristics. Based on patient's activity levels, self-reported momentary mental states, health-related behaviours and environmental and clinical background factors, the app will enable patient-tailored recommendations relevant to improving lifestyle behaviours during daily life. In addition, patients will receive a blood pressure monitor that measures hemodynamic parameters through pulse wave analysis (PWA) and an easy-to-use ECG device which will be used to assess changes in heart rate and other cardiovascular measures at rest and with exercise.
Sponsors & Collaborators
-
Klinik Königsfeld, Ennepetal, Germany
collaborator UNKNOWN -
Servicio Gallego de Salud
collaborator OTHER_GOV -
Tilburg University
lead OTHER
Principal Investigators
-
Jos Bosch, PhD · University of Amsterdam
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-14
- Primary Completion
- 2025-05-07
- Completion
- 2025-05-07
Countries
- Germany
- Netherlands
- Spain
Study Locations
More Related Trials
-
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
NCT04957719 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes
NCT02265068 ·Status: COMPLETED
-
Complete vs Culprit-only Revascularization to Treat Multi-vessel Disease After Early PCI for STEMI
NCT01740479 ·Status: COMPLETED ·Phase: NA
-
Effects of Ticagrelor on No-reflow in Patients With Acute ST-segment Elevation Myocardial Infarction
NCT02798874 ·Status: UNKNOWN ·Phase: NA
-
Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction
NCT03991143 ·Status: COMPLETED ·Phase: PHASE2
-
Standard (180mg) Versus Double (360mg) Loading Dose of Ticagrelor in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)
NCT01575795 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Early PCSK9 Inhibitor on Heart After Acute Myocardium Infarction
NCT04731155 ·Status: RECRUITING ·Phase: PHASE4
-
Subcutaneous Cardiac Monitoring of Patients With BTK Inhibitors
NCT06029166 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Optimizing Timing of CABG in Patients Presenting With ACS and Treated With Ticagrelor
NCT02627521 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Versus Late Loading of Ticagrelol in Patients With STEMI
NCT04267224 ·Status: UNKNOWN
-
Impact on Public HEalth of a Network in Acute Myocardial Infarction Care
NCT02501070 ·Status: COMPLETED
-
Methylnaltrexone as a Method to Improve Ticagrelor Uptake in Morphine Treated STEMI Patients
NCT02942550 ·Status: COMPLETED ·Phase: PHASE4
-
RETRIEVE-AMI Study
NCT05307965 ·Status: COMPLETED ·Phase: NA
-
Prasugrel vs. Ticagrelor on Myocardial Injury in STEMI
NCT03435133 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of MEDI6012 in Acute ST Elevation Myocardial Infarction
NCT03578809 ·Status: COMPLETED ·Phase: PHASE2
-
Secondary Cardiovascular Prevention Post-acute Myocardial Infarction (AMI) Through a Web-based Empowerment Program
NCT05782023 ·Status: UNKNOWN ·Phase: NA
-
Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome
NCT02037412 ·Status: TERMINATED ·Phase: PHASE4
-
Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry
NCT02271022 ·Status: COMPLETED
-
The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease
NCT02107144 ·Status: COMPLETED ·Phase: PHASE4
-
STrategic Reperfusion in Elderly Patients Early After Myocardial Infarction
NCT02777580 ·Status: COMPLETED ·Phase: PHASE4
-
Ticagrelor in Remote Ischemic Preconditioning Study
NCT04174261 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
NCT05102019 ·Status: RECRUITING ·Phase: NA
-
Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor
NCT02422888 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Pretreatment With Ticagrelor on Residual Thrombus After PCI in Patients Presenting With ACS in Comparison With Delayed Treatment at the Time of PCI: an OCT Study
NCT01916902 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Classic Secondary Prevention in Type 2 MI: A Target Trial Emulation Study
NCT06736353 ·Status: COMPLETED